HRID2039871

反应详情

EQUATION

反应方程式

REACTANTS

反应物

HCID313

Hydrochloric Acid

ClH

结构：COC(=O)CC1CN(C(=O)c2c(Oc3c(C)cccc3C)n(-c3ccccc3)c3cccnc23)CCN1C(=O)OC(C)(C)C

HCID66922257

未命名化合物

结构：COC(=O)CC1CN(C(=O)c2c(Oc3c(C)cccc3C)n(-c3ccccc3)c3cccnc23)CCN1.Cl.Cl

HCID66922395

未命名化合物

PRODUCTS

生成物

结构：COC(=O)CC1CN(C(=O)c2c(Oc3c(C)cccc3C)n(-c3ccccc3)c3cccnc23)CCN1

HCID56668563

未命名化合物

收率 39%

PROCEDURE

实验过程

The crude compound of step 2 (40 mg) was reacted analogously as described in example 1, step 7, the obtained product dissolved in a small quantity of MOH, mixed with hydrochloric acid (0.1 M) and lyophilized overnight to give 13 mg of the title compound in the form of the {4-[2-(2,6-dimethyl-phenoxy)-1-phenyl-1H-pyrrolo[3,2-b]pyridine-3-carbonyl]-piperazin-2-yl}-acetic acid methyl ester dihydrochloride.

WORKUP

后处理

dissolutionthe obtained product dissolved in a small quantity of MOH

来源与证据

来源类型: Open Reaction Database
ORD 记录: ord-1630a82b51424e778ec20bdf46a0a272
来源数据集: uspto-grants-2013_11
DOI: 10.6084/m9.figshare.5104873.v1
专利: US08580813B2
来源说明: uspto-grants-2013_11

反应 SMILES

C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]([C:16]2[C:20]3=[N:21][CH:22]=[CH:23][CH:24]=[C:19]3[N:18]([C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=3)[C:17]=2[O:31][C:32]2[C:37]([CH3:38])=[CH:36][CH:35]=[CH:34][C:33]=2[CH3:39])=[O:15])[CH2:10][CH:9]1[CH2:40][C:41]([O:43][CH3:44])=[O:42])=O)(C)(C)C.Cl.Cl.Cl.COC(=O)CC1CN(C(C2C3=NC=CC=C3N(C3C=CC=CC=3)C=2OC2C(C)=CC=CC=2C)=O)CCN1>>[CH3:44][O:43][C:41](=[O:42])[CH2:40][CH:9]1[CH2:10][N:11]([C:14]([C:16]2[C:20]3=[N:21][CH:22]=[CH:23][CH:24]=[C:19]3[N:18]([C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=3)[C:17]=2[O:31][C:32]2[C:33]([CH3:39])=[CH:34][CH:35]=[CH:36][C:37]=2[CH3:38])=[O:15])[CH2:12][CH2:13][NH:8]1